Abstract
We evaluated the effect of 2 years’ therapy with an angiotensin converting enzyme inhibitor (captopril) in 16 patients who had severe reflux nephropathy and microalbuminuria. During the period of therapy, microalbuminuria decreased, glomerular filtration rate measured by diethylenetriamine pentaacetate scan, serum creatinine, and blood pressure remained stable. We suggest the captopril was useful in reducing microalbuminuria and may have slowed the progression of renal damage in our patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received November 12, 1996; received in revised form and accepted June 23, 1997
Rights and permissions
About this article
Cite this article
Lama, G., Salsano, M., Pedulla’, M. et al. Angiotensin converting enzyme inhibitors and reflux nephropathy: 2-year follow-up. Pediatr Nephrol 11, 714–718 (1997). https://doi.org/10.1007/s004670050373
Published:
Issue Date:
DOI: https://doi.org/10.1007/s004670050373